Acute coronary syndromes: 2. Antiplatelet agents |
| |
| Authors: | DJ Schneider PB Tracy BE Sobel |
| |
| Affiliation: | Department of Medicine, University of Vermont School of Medicine, Burlington, USA. |
| |
| Abstract: | Therapies with novel antiplatelet agents and anticoagulants are the focus of current research. When used separately or in combination, these agents prevent generation of thrombin by activated platelets. The new therapies, in conjunction with judicious use of fibrinolytic drugs and mechanical interventions, are revolutionizing the management of patients with acute coronary syndromes. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
